“토론토B CDDC7¸COM 프로모션코드 B77 영등포블랙잭ÅMLB보는곳৶가상축구결과☍프로배구일정결과😜진안복권방/”的搜索结果，显示 51-60 项，共有 3732 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

2. 肾病和高血压- 临床试验- 妙佑医疗国际

   This study is being done to gather information regarding your health in relation to your composite tissue transplant. We would like to use your medical ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate immune profile of Acute Myeloid Leukemia (AML) patients receiving Venetoclax plus Azacitidine induction chemotherapy.

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase III trial compares memantine to usual treatment in treating patients with brain tumors that are newly diagnosed or has come back (recurrent).

5. 肾病和高血压- 临床试验- 妙佑医疗国际

   This study is being done to gather information regarding your health in relation to your composite tissue transplant. We would like to use your medical ...

6. 肾病和高血压- 临床试验- 妙佑医疗国际

   This study is being done to gather information regarding your health in relation to your composite tissue transplant. We would like to use your medical ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... B) of CA-4948 in patients with RR NHL with and without myeloid differentiation primary response 88 (MYD88) mutations. During Part B, patients will be ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma. Rochester, Minn., Scottsdale/Phoenix ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma. Rochester, Minn., Scottsdale/Phoenix ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma. Rochester, Minn., Scottsdale/Phoenix ...